Not Yet RecruitingNCT06971328
This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand what acceptance and commitment therapy, a talking treatment, could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Months
- Countries
- Turkey
- Sponsor
- Ataturk University
- Condition
- Schizophrenia
Active Not RecruitingNCT06945627
This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Belgium, Israel, Italy, Norway
- Sponsor
- Sara Poletti
- Condition
- Schizophrenia
TerminatedNCT03351244
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Canada, France, Japan, South Korea, Spain, Taiwan, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
RecruitingNCT06386588
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia
CompletedNCT05582980
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- Tri-Service General Hospital
- Condition
- Schizophrenia
Not Yet RecruitingNCT06964477
This study exists to understand how the medication Extended holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Extended can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- Chia-Hui Hung
- Condition
- Schizophrenia
CompletedNCT05944510
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Condition
- Schizophrenia
Not Yet RecruitingNCT06938997
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
- Condition
- Schizophrenia
CompletedNCT05528146
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherOver 20 Years
- Countries
- Taiwan
- Sponsor
- Hungkuang University
- Condition
- Schizophrenia
RecruitingNCT06958341
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
SchizophreniaOther
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
- Condition
- Schizophrenia
RecruitingNCT06835556
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
Active Not RecruitingNCT06245213
This study exists to understand whether the medication ANAVEX3-71 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication ANAVEX3-71 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Anavex Life Sciences Corp.
- Condition
- Schizophrenia
CompletedNCT06136936
This study exists to see whether the medication CT-156 is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication CT-156 in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
Active Not RecruitingNCT06453174
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 12 Years to 35 Years
- Countries
- Spain
- Sponsor
- Instituto de Investigación Biomédica de Salamanca
- Condition
- Schizophrenia
Active Not RecruitingNCT05461885
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what helps a medication treatment stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Denmark
- Sponsor
- Rigshospitalet, Denmark
- Condition
- Schizophrenia
CompletedNCT02431702
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Brazil, Mexico, United States
- Sponsor
- Janssen Scientific Affairs, LLC
- Condition
- Schizophrenia
CompletedNCT03345342
This study exists to explore whether the medication Paliperidone could improve care and understanding. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Argentina, Australia, Brazil, Bulgaria, Czech Republic, France, China, Hungary, India, Italy, Malaysia, Mexico, Poland, Russian Federation, South Africa, South Korea, Spain, Taiwan, Turkey, Ukraine, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT01819818
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOther
- Countries
- South Korea
- Sponsor
- Janssen Korea, Ltd., Korea
- Condition
- Schizophrenia
CompletedNCT03629951
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- India
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT03713658
This study exists to see whether the medication Oral is workable and worth testing more broadly. Researchers are trying to understand what the medication Oral could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Rwanda
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT04940039
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 19 Years to 34 Years
- Countries
- Rwanda
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia
CompletedNCT00460512
This study exists to understand whether the medication Flexibly is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Flexibly in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Belgium, Bulgaria, Croatia, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Latvia, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Serbia, Spain, Sweden, Switzerland, Turkey, United Kingdom
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia
CompletedNCT02713282
This study exists to explore whether the medication Transition could improve care and understanding. Researchers are trying to understand whether the medication Transition can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Croatia, Denmark, France, Germany, Greece, Israel, Malaysia, Netherlands, Russian Federation, Saudi Arabia, South Korea, Spain, Taiwan, Turkey, United Kingdom
- Sponsor
- Janssen-Cilag Ltd.
- Condition
- Schizophrenia
CompletedNCT03571685
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Janssen Scientific Affairs, LLC
- Condition
- Schizophrenia
CompletedNCT03809325
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Belgium, France, Germany, Hungary, Italy, Spain, United Kingdom
- Sponsor
- Janssen-Cilag International NV
- Condition
- Schizophrenia